Boston Scientific Corporation (BIT:1BSX)

Market Cap	135.07B
Revenue (ttm)	16.24B
Net Income (ttm)	1.88B
Shares Out	n/a
EPS (ttm)	1.27
PE Ratio	71.85
Forward PE	34.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27
Average Volume	48
Open	92.20
Previous Close	92.00
Day's Range	91.40 - 92.20
52-Week Range	67.00 - 103.00
Beta	n/a
RSI	62.32
Earnings Date	Apr 23, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD